{"symbol": "NWBO", "name": "Northwest Biotherapeutics", "next_earnings_utc": 1592253000, "next_earnings_period_start_date_utc": 1585612800, "next_earnings_period_end_date_utc": 1593475200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q2", "next_earnings_year": 2020, "next_earnings_quarter": 2, "next_earnings_revenue_num_analysts": null, "next_earnings_revenue_consensus": null, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": null, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 0, "analysts_sell": null, "analysts_buy": null, "analysts_outperform": null, "analysts_hold": null, "analysts_underperform": null, "webpage": "nwbio.com", "year_founded": 1996, "street_address": "4800 Montgomery Lane", "city": "Bethesda", "state": "MD", "zipcode": "20814", "country": "United States", "phone_number": "240-497-9024", "short_description": "Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally.", "long_description": "Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient\u00e2\u20ac\u2122s own immune system to attack cancer. It is developing DCVax-L, a product in Phase III clinical trials to treat Glioblastome multiforme, a brain cancer; and DCVax-Direct, a product in Phase I/II clinical trials to treat various types of inoperable solid tumor cancers. The company was founded in 1996 and is headquartered in Bethesda, Maryland.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "OTCQB", "equity_type": "stocks", "market_cap": 234327607, "total_enterprise": 251987607, "number_of_employees": 17, "outstanding_shares": 689198847, "eps": -0.035973, "diluted_eps": -0.035973, "earnings_from_cont_operations": -20296000, "gross_profit": -11180000, "cash": 372000, "total_debt": 18032000, "total_revenue": 2410000, "cash_from_operations": -31859000, "net_income": -20296000, "ebitda": -27442000, "year_low_stock_price": 0.14, "year_high_stock_price": 0.419, "seekingalpha_follower_count": 10830, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/NWBO.png"}